title: 72nd annual meeting of the American Academy of Dermatology.
authors.affiliation: Adis, Auckland, New Zealand, der@adis.com.
authors.forename: Kathy
authors.initials: K
authors.lastname: Fraser
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications; D001896:Boron Compounds / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000627:therapeutic use; D000068438:Brimonidine Tartrate; D003863:Depression / Q000188:drug therapy; D003876:Dermatitis, Atopic / Q000150:complications; D005512:Food Hypersensitivity / Q000150:complications; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007559:Ivermectin / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010789:Phototherapy / Q000379:methods; D010880:Piperidines / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D011810:Quinoxalines / Q000627:therapeutic use; D012871:Skin Diseases / Q000628:therapy*; D012955:Societies, Medical; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use; D014481:United States
chemical_list: D000935:Antifungal Agents; D001896:Boron Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D007155:Immunologic Factors; D010726:Phosphodiesterase Inhibitors; D010880:Piperidines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D011758:Pyrroles; D011810:Quinoxalines; D014230:Triazoles; D000068438:Brimonidine Tartrate; D013792:Thalidomide; D007559:Ivermectin; C479163:tofacitinib; D019274:Botulinum Toxins, Type A; C431707:efinaconazole; C512998:tavaborole; C505730:apremilast